Immunomics: discovering new targets for vaccines and therapeutics.

[1]  H. Dockrell,et al.  Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2]  Janice M Reichert,et al.  Monoclonal antibody successes in the clinic , 2005, Nature Biotechnology.

[3]  C. Griscelli,et al.  Immunotherapy of inflammatory diseases, 2005 , 2005, Expert opinion on biological therapy.

[4]  N. Sarvetnick,et al.  T cell homeostasis in tolerance and immunity , 2005, Journal of leukocyte biology.

[5]  S. Stevanović.  Antigen processing is predictable: From genes to T cell epitopes. , 2005, Transplant immunology.

[6]  ANDREAS SCHREIBER,et al.  3D‐Epitope‐Explorer (3DEX): Localization of conformational epitopes within three‐dimensional structures of proteins , 2005, J. Comput. Chem..

[7]  Urmila Kulkarni-Kale,et al.  CEP: a conformational epitope prediction server , 2005, Nucleic Acids Res..

[8]  M. D’Elios,et al.  Human 60-kDa Heat Shock Protein Is a Target Autoantigen of T Cells Derived from Atherosclerotic Plaques 1 , 2005, The Journal of Immunology.

[9]  L. K. Ely,et al.  Antagonism of Antiviral and Allogeneic Activity of a Human Public CTL Clonotype by a Single Altered Peptide Ligand: Implications for Allograft Rejection 1 , 2005, The Journal of Immunology.

[10]  Uwe Kärst,et al.  Comparative proteome analysis of secretory proteins from pathogenic and nonpathogenic Listeria species , 2005, Proteomics.

[11]  John Sidney,et al.  Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity , 2005, The Journal of Immunology.

[12]  L. Juliano,et al.  T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. , 2005, Journal of autoimmunity.

[13]  R. Welsh,et al.  Private specificities of CD8 T cell responses control patterns of heterologous immunity , 2005, The Journal of experimental medicine.

[14]  P. Bifani,et al.  Immunological Characterization of Novel Secreted Antigens of Mycobacterium tuberculosis , 2005, Scandinavian journal of immunology.

[15]  Dwaine F Emerich,et al.  Nanomedicine – prospective therapeutic and diagnostic applications , 2005, Expert opinion on biological therapy.

[16]  Anne S De Groot,et al.  From genome to vaccine--new immunoinformatics tools for vaccine design. , 2004, Methods.

[17]  Todd M. Allen,et al.  High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. , 2004, Gastroenterology.

[18]  W. Sterry,et al.  New and emerging vaccination strategies for prevention and treatment of dermatological diseases , 2004, Expert review of vaccines.

[19]  Marc R Wilkins,et al.  Using proteomics to mine genome sequences. , 2004, Journal of proteome research.

[20]  G. Nepom,et al.  MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete. , 2004, Clinical immunology.

[21]  R. Valenta,et al.  Can we genetically engineer safer and more effective immunotherapy reagents? , 2003, Current opinion in allergy and clinical immunology.

[22]  M. D’Elios,et al.  Molecular Mimicry between Helicobacter pylori Antigens and H+,K+–Adenosine Triphosphatase in Human Gastric Autoimmunity , 2003, The Journal of experimental medicine.

[23]  Stuart M. Brown,et al.  Genomics‐based identification of self‐ligands with T cell receptor‐specific biological activity , 2002, Immunological reviews.

[24]  A. Mustafa.  Development of new vaccines and diagnostic reagents against tuberculosis. , 2002, Molecular immunology.

[25]  G. Laurie,et al.  Human genome search in celiac disease: mutated gliadin T-cell-like epitope in two human proteins promotes T-cell activation. , 2002, Journal of molecular biology.

[26]  S. Cawley,et al.  Profiling the malaria genome: a gene survey of three species of malaria parasite with comparison to other apicomplexan species. , 2001, Molecular and biochemical parasitology.

[27]  N. Viner,et al.  T Cell Recognition of the Dominant I-Ak–Restricted Hen Egg Lysozyme Epitope , 2001, The Journal of experimental medicine.

[28]  S. Reed,et al.  Mass Spectrometric Identification of Mtb81, a Novel Serological Marker for Tuberculosis , 2000, Journal of Clinical Microbiology.

[29]  J. Venter,et al.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. , 2000, Science.

[30]  T. Kirchner,et al.  The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. , 1998, Gastroenterology.

[31]  Erwin L Roggen,et al.  An in silico method using an epitope motif database for predicting the location of antigenic determinants on proteins in a structural context , 2006, Journal of molecular recognition : JMR.

[32]  W. Martin,et al.  De-immunization of therapeutic proteins by T-cell epitope modification. , 2005, Developments in biologicals.

[33]  E. Carter,et al.  Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes. , 2005, Tuberculosis.

[34]  N. Rose,et al.  Thyroglobulin as Autoantigen: Structure–Function Relationships , 2004, Reviews in Endocrine and Metabolic Disorders.

[35]  I. Orme,et al.  Proteomic approaches to antigen discovery. , 2004, Methods in molecular medicine.

[36]  J. Markmann,et al.  Homeostatic proliferation is a barrier to transplantation tolerance , 2004, Nature Medicine.

[37]  Rosenberg As.  Immunogenicity of biological therapeutics: a hierarchy of concerns. , 2003, Developments in biologicals.